• 1
    Pastor P, Makuc DM, Reuben C, Xia H. Chartbook on Trends in the Health of Americans. Health, United States, 2002. Hyattsville, Maryland: National Center for Health Statistics, 2002.
  • 2
    International Obesity Task Force., 2003.
  • 3
    Seidell JC. Prevalence and time trends of obesity in Europe. J Endocrinol 2002; 25: 81622.
  • 4
    Martinez JA, Kearney JM, Kafatos A, Paquet S, Martinez-Gonzales MA. Variables independently associated with self-reported obesity in the European Union. Public Health Nutr 1999; 2: 12533.
  • 5
    Maillard G, Charles MA, Tibult N. Trends in the prevalence of obesity in the French adult population between 1980 and 1991. Int J Obes Relat Metab Disord 1999; 23: 38994.
  • 6
    Flegal KM, Caroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 1998; 22: 3947.
  • 7
    Popkin BM. The Nutrition Transition and Obesity in the Developing World. J Nutr 2001; 131: 871S873S.
  • 8
    Shetty PS. Obesity in children in developing societies: indicator of economic progress or a prelude to a health disaster? Indian Pediatr 1999; 36: 1115.
  • 9
    Fall CHD. Non-industrialised countries and affluence. Br Med Bull 2001; 60: 3355.
  • 10
    World Health Organisation. Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organisation, 1998.
  • 11
    Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science 1998; 280: 13714.
  • 12
    French SA, Story M, Jeffery RW. Environmental influences on eating and physical activity. Ann Rev Public Health 2001; 22: 30935.
  • 13
    Unger RH, Orci L. Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 2000; 24: S2832.
  • 14
    Eaton SB, Konner M, Shotak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med 1988; 84: 73949.
  • 15
    Neel J. Diabetes mellitus: a ‘thrifty’ genotype rendered detrimental by ‘progress’? Am J Hum Genet 1962; 14: 35362.
  • 16
    Stubbs RJ, Harbron CG, Murgatroyd PR, Prentice AM. Covert manipulation of dietary fat and energy density: effect on substrate flux and food intake in men eating ad libitum. Am J Clin Nutr 1995; 62: 31629.
  • 17
    Ravussin E, Valencia ME, Esparza J, Bennett PH, Schulz O. Effects of a traditional lifestyle on obesity in Pima Indians. Diabetes Care 1994; 17: 106774.
  • 18
    Bouchard C, Tremblay A, Despres JP et al. The response to long-term overfeeding in identical twins. N Engl J Med 1990; 322: 147782.
  • 19
    Bouchard C, Tremblay A, Despres JP, Theriault G, Nadeau A, Lupien PJ et al. The response to exercise with constant energy intake in identical twins. Obes Res 1994; 2: 40010.
  • 20
    Allison DB, Kaprio J, Korkeila M, Koskenvuo M, Neale M, Hayakawa K. The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord 1996; 20: 5016.
  • 21
    Comuzzie AG, Blangero J, Mahaney MC et al. Genetic and environmental correlations among hormone levels and measures of body fat accumulation and topography. J Clin Endocrinol Metab 1996; 81: 597600.
  • 22
    Price RA, Gottesman II. Body fat in identical twins reared apart: roles for genes and environment. Behav Genet 1991; 21: 17.
  • 23
    Stunkard AJ, Sorensen TI, Hanis C et al. An adoption study of human obesity. N Engl J Med 1986; 314: 1938.
  • 24
    Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human obesity. Behav Genet 1997; 27: 32551.
  • 25
    Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body mass index of twins who have been reared apart. N Engl J Med 1990; 322: 14837.
  • 26
    Sorensen TIA, Holst C, Stunkard AJ. Childhood body mass index – genetic and familial environmental influences assessed in a longitudinal adoption study. Int J Obes Relat Metab Disord 1992; 16: 70514.
  • 27
    Sorensen TIA, Holst C, Stunkard AJ, Skovgaard LT. Correlations of body mass index of adult adoptees and their biological and adoptive relatives. Int J Obes Relat Metab Disord 1992; 16: 22736.
  • 28
    Vogler GP, Sorensen TI, Stunkard AJ, Srinivasan MR, Rao DC. Influences of genes and shared family environment on adult body mass index assessed in an adoption study by a comprehensive path model. Int J Obes Relat Metab Disord 1995; 19: 4045.
  • 29
    Rice T, Perusse L, Bouchard C, Rao DC. Familial aggregation of body mass index and subcutaneous fat measures in the longitudinal Quebec Family Study. Genet Epidemiol 1999; 16: 31634.
  • 30
    Risch N. Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am J Hum Genet 1990; 46: 24253.
  • 31
    Allison DB, Faith J, Nathan JS. Risch's lambda values for human obesity. Int J Obes Relat Metab Disord 1996; 20: 9909.
  • 32
    Lee JH, Reed DR, Price RA. Familial risk ratios for extreme obesity: implications for mapping human obesity genes. Int J Obes Relat Metab Disord 1997; 21: 93540.
  • 33
    Katzmarzyk PT, Perusse L, Rao DC, Bouchard C. Familial risk of obesity and central adipose tissue distribution in the general Canadian population. J Clin Endocrinol Metab 1999; 84: 20937.
  • 34
    Chagnon YC, Rankinen T, Snyder EE, Weisnagel SJ, Perusse L, Bouchard C. The human obesity gene map: The 2002 update. Obes Res 2003; 11.
  • 35
    Ohta T, Gray TA, Rogan PK et al. Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet 1999; 64: 397413.
  • 36
    Ming JE, Blagowidow N, Knoll JH et al. Submicroscopic deletion in cousins with Prader-Willi syndrome causes a grandmatrilineal inheritance pattern: effects of imprinting. Am J Med Genet 2000; 92: 1924.
  • 37
    Meguro M, Mitsuya K, Nomura N et al. Large-scale evaluation of imprinting status in the Prader-Willi syndrome region: an imprinted direct repeat cluster resembling small nucleolar RNA genes. Hum Mol Genet 2001; 10: 38394.
  • 38
    Gallagher RC, Pils B, Albawi M, Francke U. Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet 2002; 71: 66978.
  • 39
    Ishikawa Y, Tajima T, Nakae J et al. Two mutations of the Gsalpha gene in two Japanese patients with sporadic pseudohypoparathyroidism type Ia. J Hum Genet 2001; 46: 42630.
  • 40
    Ahmed SF, Dixon PH, Bonthron DT et al. GNAS1 mutational analysis in pseudohypoparathyroidism. Clin Endocrinol (Oxf) 1998; 49: 52531.
  • 41
    Aldred MA, Trembath RC. Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat 2000; 16: 1839.
  • 42
    Rickard SJ, Wilson LC. Analysis of GNAS1 and Overlapping Transcripts Identifies the Parental Origin of Mutations in Patients with Sporadic Albright Hereditary Osteodystrophy and Reveals a Model System in Which to Observe the Effects of Splicing Mutations on Translated and Untranslated Messenger RNA. Am J Hum Genet 2003; 72: 96174.
  • 43
    Katsanis N, Ansley SJ, Badano JL et al. Triallelic Inheritance in Bardet-Biedl Syndrome, a Mendelian Recessive Disorder. Science 2001; 293: 22569.
  • 44
    Katsanis N, Lewis RA, Stockton DW et al. Delineation of the critical interval of Bardet-Biedl syndrome 1 (BBS1) to a small region of 11q13, through linkage and haplotype analysis of 91 pedigrees. Am J Hum Genet 1999; 65: 16729.
  • 45
    Young TL, Woods MO, Parfrey PS, Green JS, Hefferton D, Davidson WS. A founder effect in the newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM. Am J Hum Genet 1999; 65: 16807.
  • 46
    Mykytyn K, Nishimura DY, Searby CC et al. Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet 2002; 31: 4358.
  • 47
    Mykytyn K, Nishimura DY, Searby CC et al. Evaluation of Complex Inheritance Involving the Most Common Bardet-Biedl Syndrome Locus (BBS1). Am J Hum Genet 2003; 72: 42937.
  • 48
    Nishimura DY, Searby CC, Carmi R et al. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet 2001; 10: 86574.
  • 49
    Mykytyn K, Braun T, Carmi R et al. Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet 2001; 28: 18891.
  • 50
    Konrad RJ, Kudlow JE. The role of O-linked protein glycosylation in beta-cell dysfunction. Int J Mol Med 2002; 10: 5359.
  • 51
    Katsanis N, Eichers ER, Ansley SJ et al. BBS4 is a minor contributor to Bardet-Biedl syndrome and may also participate in triallelic inheritance. Am J Hum Genet 2002; 71: 2229.
  • 52
    Katsanis N, Beales PL, Woods MO et al. Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat Genet 2000; 26: 6770.
  • 53
    Slavotinek AM, Searby CC, Al-Gazali L et al. Mutation analysis of the MKKS gene in McKusick-Kaufman syndrome and selected Bardet-Biedl syndrome patients. Hum Genet 2002; 110: 5617.
  • 54
    Slavotinek AM, Stone EM, Mykytyn K et al. Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet 2000; 26: 1516.
  • 55
    Katsanis N, Lupski JR, Beales PL. Exploring the molecular basis of Bardet-Biedl syndrome. Hum Mol Genet 2001; 10: 22939.
  • 56
    Reed DR, Ding Y, Xu W, Cather C, Price RA. Human obesity does not segregate with the chromosomal regions of Prader-Willi, Bardet-Biedl, Cohen, Borjeson or Wilson-Turner syndromes. Int J Obes Relat Metab Disord 1995; 19: 599603.
  • 57
    Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973; 9: 2948.
  • 58
    Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 42532.
  • 59
    Tartaglia LA, Dembski M, Weng X et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 126371.
  • 60
    Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002; 26: 140733.
  • 61
    Porte D, Jr, Baskin DG, Schwartz MW. Leptin and insulin action in the central nervous system. Nutr Rev 2002; 60: S2029.
  • 62
    Montague CT, Farooqi IF, Whitehead JP et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1995; 387: 9038.
  • 63
    Farooqi IS, Matarese G, Lord GM et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002; 110: 1093103.
  • 64
    Rau H, Reaves BJ, O'Rahilly S, Whitehead JP. Truncated Human Leptin (Delta133) Associated with Extreme Obesity Undergoes Proteasomal Degradation after Defective Intracellular Transport. Endocrinology 1999; 140: 171823.
  • 65
    Farooqi IS, Keogh JM, Kamath S et al. Partial leptin deficiency and human adiposity. Nature 2001; 414: 3435.
  • 66
    Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998; 18: 2135.
  • 67
    Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999; 84: 368695.
  • 68
    Farooqi IS, Jebb SA, Langmack G et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 87984.
  • 69
    Chen H, Charlat O, Tartaglia LA et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84: 4915.
  • 70
    Lee GH, Proenca R, Montez JM et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 6325.
  • 71
    Phillips MS, Liu Q, Hammond HA et al. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 1996; 13: 1819.
  • 72
    Clement K, Vaisse C, Lahlou N et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398401.
  • 73
    Flier SJ, Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell 1998; 92: 43740.
  • 74
    Krude H, Bierbermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998; 19: 1557.
  • 75
    Wardlaw SL. Obesity as a neuroendocrine disease: lessons to be learned from proopiomelanocortin and melanocortin receptor mutations in mice and men. J Clin Endocrinol Metab 2001; 86: 14426.
  • 76
    Yeo GSH, Farooqi IS, Aminian S, Halsall D, Stanhope RG, O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998; 20: 1112.
  • 77
    Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998; 20: 1134.
  • 78
    Sina M, Hinney A, Ziegler A et al. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am J Hum Genet 1999; 65: 15017.
  • 79
    Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000; 106: 25362.
  • 80
    Gu W, Tu Z, Kleyn PW et al. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 1999; 48: 6359.
  • 81
    Farooqi IS, Yeo GSH, Keogh JM et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106: 2719.
  • 82
    Mergen M, Mergen H, Ozata M, Oner R, Oner C. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 2001; 86: 3448.
  • 83
    Hinney A, Schmidt A, Nottebom K et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999; 84: 14836.
  • 84
    Dubern B, Clement K, Pelloux V et al. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr 2001; 139: 2049.
  • 85
    Kobayashi H, Ogawa Y, Shintani M et al. A novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Diabetes 2002; 51: 2436.
  • 86
    Jacobson P, Ukkola O, Rankinen T et al. Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish obese subjects, the HERITAGE family study, and a Memphis cohort. J Clin Endocrinol Metab 2002; 87: 44426.
  • 87
    Miraglia del Giudice E, Cirillo G, Nigro V et al. Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Int J Obes Relat Metab Disord 2002; 26: 64751.
  • 88
    Marti A, Corbalan MS, Forga L, Martinez JA, Hinney A, Hebebrand J. A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population. Int J Obes Relat Metab Disord 2003; 27: 3858.
  • 89
    Farooqi IS, Keogh JM, Yeo GSH, Lank EJ, Cheetham T, O'Rahilly S. Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene. N Engl J Med 2003; 348: 108595.
  • 90
    Branson R, Potoczna N, Kral JG, Lentes KU, Hoehe MR, Horber FF. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 348: 1096103.
  • 91
    Ho G, MacKenzie RG. Functional characterization of mutations in melanocortin-4 receptor associated with human obesity. J Biol Chem 1999; 274: 35 81622.
  • 92
    Yeo GSH, Lank EJ, Farooqi IF, Keogh JM, Challis BG, O'Rahilly S. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet 2003; 12: 56174.
  • 93
    Naggert JK, Fricker LD, Varlamov O et al. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 1995; 10: 13542.
  • 94
    Jackson RS, Creemers JW, Ohagi S et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1998; 16: 3036.
  • 95
    Oppert JM, Vohl MC, Chagnon M et al. DNA polymorphism in the uncoupling protein (UCP) gene and human body fat. Int J Obes Relat Metab Disord 1994; 18: 52631.
  • 96
    Fumeron F, Durack-Brown I, Betoulle D et al. Polymorphisms of uncoupling protein (UCP) and beta 3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int J Obes Relat Metab Disord 1996; 20: 10514.
  • 97
    Kogure A, Yoshida T, Sakane N, Umekawa T, Takakura Y, Kondo M. Synergic effect of polymorphisms in uncoupling protein 1 and β3-adrenergic receptor genes on weight loss in obese Japanese. Diabetologia 1998; 41: 1399.
  • 98
    Heilbronn LK, Kind KL, Pancewicz E, Morris AM, Noakes M, Clifton PM. Association of -3826 G variant in uncoupling protein-1 with increased BMI in overweight Australian women. Diabetologia 2000; 43: 2424.
  • 99
    Ukkola O, Tremblay A, Sun G, Chagnon YC, Bouchard C. loci and the response to long-term overfeeding. Eur J Clin Nutr 2001; 55: 100815.
  • 100
    Walder K, Norman RA, Schrauwen P et al. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. Hum Mol Genet 1998; 7: 14315.
  • 101
    Astrup A, Toubro S, Dalgaard LT, Urhammer SA, Sorensen TI, Pedersen O. Impact of the v/v 55 polymorphism of the uncoupling protein 2 gene on 24-h energy expenditure and substrate oxidation. Int J Obes Relat Metab Disord 1999; 23: 10304.
  • 102
    Urhammer SA, Dalgaard LT, Sorensen TI et al. Mutational analysis of the coding region of the uncoupling protein 2 gene in obese NIDDM patients: impact of a common amino acid polymorphism on juvenile and maturity onset forms of obesity and insuline resistance. Diabetologia 1997; 40: 122730.
  • 103
    Evans D, Wolf AM, Nellessen U et al. Association between polymorphisms in candidate genes and morbid obesity. Int J Obes Relat Metab Disord 2001; 25: S1921.
  • 104
    Cassell PG, Neverova M, Janmohamed S et al. An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. Diabetologia 1999; 42: 68892.
  • 105
    Yanovski JA, Diament AL, Sovik KN et al. Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, white, and Asian children. Am J Clin Nutr 2000; 71: 140520.
  • 106
    Evans D, Minouchehr S, Hagemann G et al. Frequency of and interaction between polymorphisms in the beta3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans. Int J Obes 2000; 24: 123945.
  • 107
    Nordfors L, Heimburger O, Lonnqvist F et al. Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int 2000; 57: 17139.
  • 108
    Lanouette CM, Giacobino J-P, Perusse L et al. Association between uncoupling protein 3 gene and obesity-related phenotypes in the Quebec Family Study. Mol Med 2001; 7: 43341.
  • 109
    Lanouette CM, Chagnon YC, Rice T et al. Uncoupling protein 3 gene is associated with body composition changes with training in HERITAGE study. J Appl Physiol 2002; 92: 11118.
  • 110
    Argyropoulos G, Harper ME. Molecular biology of thermoregulation: uncoupling proteins and thermoregulation. J Appl Physiol 2002; 92: 218798.
  • 111
    Argyropoulos G, Brown AM, Willi SM et al. Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest 1998; 102: 134551.
  • 112
    Buemann B, Schiering B, Toubro S et al. The association between the val/val-55 polymorphism of the uncoupling protein 2 gene and excercise efficiency. Int J Obes Relat Metab Disord 2001; 25: 46771.
  • 113
    Otabe S, Clement K, Dina C et al. A genetic variation in the 5 flanking region of the UCP3 gene is associated with body mass index in humans in interaction with physical activity. Diabetologia 2000; 43: 2459.
  • 114
    Cassell PG, Saker PJ, Huxtable SJ et al. (UCP3) gene influences fat distribution in women of European and Asian origin. Diabetologia 3 2000; 155864.
  • 115
    Kimm SY, Glynn NW, Aston CE et al. Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am J Clin Nutr 2002; 75: 7149.
  • 116
    Blaak EE, van Baak MA, Kemerinck GJ, Pakbiers MT, Heidendal GA, Saris WHM. Beta-adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. Am J Physiol 1994; 267: E31622.
  • 117
    Lin RCY, Ericsson JO, Benjafield AV, Morris BJ. Association of beta2-adrenoceptor Gln27Glu variant with body weight but not hypertension. Am J Hypertens 2001; 14: 12014.
  • 118
    Hellström L, Large V, Reynisdottir S, Wahrenberg H, Arner P. The different effects of a Gln27Glu β2-adrenoreceptor gene polymorphism on obesity in males and females. J Intern Med 1999; 245: 2539.
  • 119
    Yamada K, Ishiyama-Shigemoto S, Ichikawa F et al. Polymorphism in the 5-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab 1999; 84: 17547.
  • 120
    Mori Y, Kim-Motoyama H, Ito Y et al. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Comm 1999; 258: 13840.
  • 121
    Large V, Hellstrom L, Reynisdottir S et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997; 100: 300513.
  • 122
    Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K. Association of polymorphisms in the beta-2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999; 42: 98101.
  • 123
    Meirhaeghe A, Helbecque N, Cottel D, Amouyel P. Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 1999; 353: 896.
  • 124
    Ehrenborg E, Skogsberg RG, Large V et al. Polymorphism in the beta2− adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins. J Intern Med 2000; 247: 6516.
  • 125
    Macho-Azcarate T, Marti A, Gonzales A, Martinez JA, Ibanez J. Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women. Int J Obes 2002; 26: 143441.
  • 126
    Green SA, Turki J, Bejarano P, Hall IP, Liggett SB. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13: 2533.
  • 127
    Emorine LJ, Marullo S, Briend-Suttern MM et al. Molecular characterization of the human beta 3-adrenergic receptor. Science 1989; 245: 111821.
  • 128
    Krief S, Lonnqvist F, Raimbault S et al. Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest 1993; 91: 3449.
  • 129
    Lafontan M. Differential recruitment and differential regulation by physiological amines of fat cell beta-1, beta-2 and beta-3 adrenergic receptors expressed in native fat cells and in transfected cell lines. Cell Signal 1994; 6: 36392.
  • 130
    Walston J, Silver K, Bogardus C et al. Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the beta3-Adrenergic-Receptor Gene. N Engl J Med 1995; 333: 3437.
  • 131
    Clement K, Vaisse C, Manning BS et al. Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 3524.
  • 132
    Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a Polymorphism in the beta3-Adrenergic-Receptor Gene with Features of the Insulin Resistance Syndrome in Finns. N Engl J Med 1995; 333: 34852.
  • 133
    Urhammer SA, Hansen T, Borch-Johnsen K, Pedersen O. Studies of the synergistic effect of the Trp/Arg64 polymorphism of the β3-adrenergic receptor gene and the -3826 A->G variant of the uncoupling protein-1 gene on features of obesity and insulin resistance in a populatio-based sample of 379 young Danish subjects. J Clin Endocrinol Metab 2000; 85: 31514.
  • 134
    Kim-Motoyama H, Yasuda K, Yamaguchi T et al. A mutation of the beta 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 1997; 40: 46972.
  • 135
    Festa A, Krugluger W, Shnawa N, Hopmeier P, Haffner SM, Schernthaner G. Trp64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus. J Clin Endocrinol Metab 1999; 84: 16959.
  • 136
    Thomas GN, Tomlinson B, Chan JC, Young RP, Critchley JA. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord 2000; 24: 54551.
  • 137
    Sipilainen R, Uusitupa M, Heikkinen S, Rissanen A, Laakso M. Polymorphism of the beta3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes 1997; 46: 7780.
  • 138
    Corbalan MS, Marti A, Forga L, Martinez-Gonzales MA, Martinez JA. The risk of obesity and the Trp64Arg polymorphism of the beta(3)-adrenergic receptor: effect modification by age. Ann Nutr Metab 2002; 46: 1528.
  • 139
    Allison DB, Heo M, Faith MS, Pietrobelli A. Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 1998; 22: 55966.
  • 140
    Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T. Meta-analysis of the association of Trp64Arg polymorphism of beta3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 1998; 83: 2441.
  • 141
    Kurokawa N, Nakai K, Kameo S, Liu ZM, Satoh H. Association of BMI with the beta3-adrenergic receptor gene polymorphism in Japanese: meta-analysis. Obes Res 2001; 9: 741.
  • 142
    Clement K, Ruiz J, Cassard-Doulcier AM et al. Additive effect of A–>G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord 1996; 20: 10626.
  • 143
    Fogelholm M, Valve R, Kukkonen-Harjula K et al. Additive effects of the mutations in beta3-adrenergic receptor and uncoupling protein-1 genes on weight loss and weight maintenance in Finnish women. J Clin Endocrinol Metab 1998; 83: 424650.
  • 144
    Sivenius K, Valve R, Lindi V, Niskanen LK, Laakso M, Uusitupa M. Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on long-term body weight change in Finnish type 2 diabetic and non-diabetic control subjects. Int J Obes Relat Metab Disord 2000; 24: 5149.
  • 145
    Ukkola O, Perusse L, Chagnon YC, Despres JP, Bouchard C. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Quebec Family Study. Int J Obes 2001; 25: 13329.
  • 146
    Ukkola O, Rankinen T, Weisnagel SJ et al. Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism 2000; 49: 106370.
  • 147
    Ukkola O, Rankinen T, Rice T et al. Interactions among the beta2- and beta3- adrenergic receptor genes and total body fat and abdominal fat level in the HERITAGE Family Study. Int J Obes Relat Metab Disord 2003; 27: 38993.
  • 148
    Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia 1999; 42: 103349.
  • 149
    Vidal-Puig AJ, Considine RV, Jimenez-Linan M et al. Peroxisome Proliferator-activated Receptor Gene Expression in Human Tissues. Effects of Obesity, Weight Loss, and Regulation by Insulin and Glucocorticoids. J Clin Invest 1997; 99: 241622.
  • 150
    Sewter C, Blows F, Considine R, Vidal-Puig A, O'Rahilly S. Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes. J Clin Endocrinol Metab 2002; 87: 42037.
  • 151
    Masugi J, Tamori Y, Mori H, Koike T, Kasuga M. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun 2000; 268: 17882.
  • 152
    Deeb SS, Fajas L, Nemoto M et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 2847.
  • 153
    Lindi VI, Uusitupa MIJ, Lindstrom J et al. Association of the Pro12Ala Polymorphism in the PPAR-gamma2 Gene With 3-Year Incidence of Type 2 Diabetes and Body Weight Change in the Finnish Diabetes Prevention Study. Diabetes 2002; 51: 25816.
  • 154
    Ek J, Urhammer SA, Sorensen TI, Andersen T, Auwerx J, Pedersen O. Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 1999; 42: 8925.
  • 155
    Beamer BA, Yen CJ, Andersen RE et al. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes 1998; 47: 18068.
  • 156
    Valve R, Sivenius K, Miettinen R et al. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999; 84: 370812.
  • 157
    Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Colantuoni V, Riccardi G. Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma2 (PPARgamma2) and severe obesity: a case–control study. Int J Obes Relat Metab Disord 2000; 24: 11959.
  • 158
    Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Amouyel P. Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 2000; 24: 1959.
  • 159
    Nicklas BJ, van Rossum EFC, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 2001; 50: 21726.
  • 160
    Hasstedt SJ, Ren QF, Teng K, Elbein SC. Effect of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds. J Clin Endocrinol Metab 2001; 86: 53641.
  • 161
    Lindi V, Sivenius K, Niskanen LK, Laakso M, Uusitupa M. Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia 2001; 44: 9256.
  • 162
    Gonzales Sanchez JL, Serrano Rios M, Fernandez Perez C, Laakso M, MartinezLarrad MT. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol 2002; 147: 495501.
  • 163
    Cole SA, Mitchell BD, Hsueh WC et al. The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans. Int J Obes Relat Metab Disord 2000; 24: 5224.
  • 164
    Valve R, Heikkinen S, Rissanen A, Laakso M, Uusitupa M. Synergistic effect of polymorphisms in uncoupling protein 1 and β3-adrenergic receptor genes on basal metabolic rate in obese Finns. Diabetologia 1998; 41: 35761.
  • 165
    Oksanen L, Ohman M, Heiman ML et al. Markers for the gene ob and serum leptin levels in human morbid obesity. Hum Genet 1997; 99: 55964.
  • 166
    Shintani M, Ikegami H, Yamato E et al. A novel microsatellite polymorphism in the human OB gene: a highly polymorphic marker for linkage analysis. Diabetologia 1996; 39: 1398401.
  • 167
    Butler MG, Hedges L, Hovis CL, Feurer ID. Genetic variants of the human obesity (OB) gene in subjects with and without Prader-Willi syndrome: comparison with body mass index and weight. Clin Genet 1998; 54: 38593.
  • 168
    Li WD, Reed DR, Lee JH et al. Sequence variants in the 5′ flanking region of the leptin gene are associated with obesity in women. Ann Hum Genet 1999; 63: 22734.
  • 169
    Karvonen MK, Pesonen U, Heinonen P et al. Identification of new sequence variants in the leptin gene. J Clin Endocrinol Metab 1998; 83: 323942.
  • 170
    Hager J, Clement K. A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels. Int J Obes Relat Metab Disord 1998; 22: 2005.
  • 171
    Mammes O, Betoulle D, Aubert R et al. Novel polymorphisms in the 5′ region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes 1998; 47: 4879.
  • 172
    Le Stunff C, Le Bihan C, Schork NJ, Bougneres P. A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes 2000; 49: 2196200.
  • 173
    Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002; 34: 3559.
  • 174
    Hinney A, Bornscheuer A, Depenbusch M et al. No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity: identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region. Mol Psychiatry 1998; 3: 53943.
  • 175
    De Silva AM, Walder KR, Aitman TJ et al. Combination of polymorphisms in OB-R and the OB gene associated with insulin resistance in Nauruan males. Int J Obes Relat Metab Disord 1999; 23: 81622.
  • 176
    Arcuri P, Di Spirito P, Di Valerio A et al. Mutational analysis of OB gene in obese and type 2 diabetes affected subjects. Int J Mol Med 2000; 6: 9799.
  • 177
    Oksanen L, Tiitinen A, Kaprio J, Koistinen H, Karonen S, Kontula K. No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome. Mol Hum Reprod 2000; 6: 8736.
  • 178
    Mattevi VS, Zembrzuski VM, Hutz MH. Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil. Int J Obes Relat Metab Disord 2002; 26: 117985.
  • 179
    Shintani M, Ikegami H, Fujisawa T et al. Leptin gene polymorphism is associated with hypertension independent of obesity. J Clin Endocrinol Metab 2002; 87: 290912.
  • 180
    Chagnon YC, Chung WK, Perusse L, Chagnon M, Leibel RL, Bouchard C. Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study. Int J Obes Relat Metab Disord 1999; 23: 27886.
  • 181
    Chagnon YC, Wilmore JH, Borecki I et al. Associations between the leptin receptor gene and adiposity in middle-ages Caucasian males from the HERITAGE Family Study. J Clin Endocrinol Metab 2000; 85: 2934.
  • 182
    Wauters M, Mertens I, Chagnon M et al. Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obes Relat Metab Disord 2001; 25: 71420.
  • 183
    Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klimis-Zacas D, Mantzoros CS. The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 2001; 86: 44349.
  • 184
    Quinton ND, Lee AJ, Ross RJM, Eastell R, Blakemore AIF. A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet 2001; 108: 2336.
  • 185
    Heo M, Leibel R, Fontaine KR et al. A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference. Int J Obes Relat Metab Disord 2002; 26: 6406.
  • 186
    Williams JT, Blangero J. Power of variance component linkage analysis to detect quantitative trait loci. Genet Epidemiol 1999; 63: 54563.
  • 187
    Comuzzie AG, Hixson JE, Almasy L et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997; 15: 2736.
  • 188
    Hixson JE, Almasy L, Cole S et al. Normal variation in leptin levels in associated with polymorphisms in the proopiomelanocortin gene, POMC. J Clin Endocrinol Metab 1999; 84: 318791.
  • 189
    Hager J, Dina C, Francke S et al. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 1998; 20: 3048.
  • 190
    Rotimi CN, Comuzzie AG, Lowe WL, Luke A, Blangero J, Cooper RS. The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes 1999; 48: 6434.
  • 191
    Comuzzie AG, Funahashi T, Sonnenberg G et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001; 86: 43215.
  • 192
    Fruebis J, Tsao TS, Javorschi S et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. PNAS 2001; 98: 200510.
  • 193
    Hotta K, Funahashi T, Arita Y et al. Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients. Arterioscler Thromb Vasc Biol 2000; 20: 15959.
  • 194
    Arita Y, Kihara S, Ouchi H et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 7983.
  • 195
    Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10 697703.
  • 196
    Vionnet N, Hani EH, Dupont S et al. Genomewide search for type 2 diabetes susceptibility genes in French Whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2 diabetes locus on chromosome 1q21q24. Am J Hum Genet 2000; 67: 1480.
  • 197
    Kissebah AH, Sonnenberg GE, Myklebust J et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. PNAS 2000; 97: 14 47883.
  • 198
    Wu X, Cooper RS, Borecki IB et al. A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet 2002; 70: 124756.
  • 199
    Zhu X, Cooper RS, Luke A et al. A genome-wide scan for obesity in African-Americans. Diabetes 2002; 51: 5414.
  • 200
    Walder K, Hanson RL, Kobes S, Knowler WC, Ravussin E. An autosomal genomic scan for loci linked to plasma leptin concentration in Pima Indians. Int J Obes Relat Metab Disord 2000; 24: 55965.
  • 201
    Rice T, Chagnon YC, Perusse L et al. A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: The HERITAGE Family Study. Diabetes 2002; 51: 84855.
  • 202
    Vijayaraghavan S, Hitman GA, Kopelman PG. Apolipoprotein-D polymorphism: a genetic marker for obesity and hyperinsulinemia. J Clin Endocrinol Metab 1994; 79: 56870.
  • 203
    Lindsay RS, Kobes S, Knowler WC, Bennett PH, Hanson RL. Genome-wide linkage analysis assessing parent-of-origin effects in the inheritance of type 2 diabetes and BMI in Pima Indians. Diabetes 2001; 50: 28507.
  • 204
    Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like Peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998; 101: 51520.
  • 205
    Zinman B, Hanley AJG, Harris SB, Kwan J, Fantus IG. Circulating Tumor Necrosis Factor-alpha Concentrations in a Native Canadian Population with High Rates of Type 2 Diabetes Mellitus. J Clin Endocrinol Metab 1999; 84: 2728.
  • 206
    Fernandez-Real JM, Gutierrez C, Ricart W et al. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997; 46: 146872.
  • 207
    Hsueh WC, Mitchell BD, Schneider JL et al. Genome-wide scan of obesity in the Old Order Amish. J Clin Endocrinol Metab 2001; 86: 1199205.
  • 208
    Feitosa MF, Borecki IB, Rich SS et al. Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet 2002; 70: 7282.
  • 209
    Duggirala R, Stern MP, Mitchell BD et al. Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am J Hum Genet 1996; 59: 694703.
  • 210
    Bray MS, Boerwinkle E, Hanis CL. Linkage analysis of candidate obesity genes among the Mexican-American population of Starr County, Texas. Genet Epidemiol 1999; 16: 397411.
  • 211
    Perusse L, Rice T, Chagnon YC et al. A genome-wide scan for abdominal fat assessed by computed tomography in the Québec Family Study. Diabetes 2001; 50: 61421.
  • 212
    Hinney A, Ziegler A, Oeffner F et al. Independent Confirmation of a Major Locus for Obesity on Chromosome 10. J Clin Endocrinol Metab 2000; 85: 29625.
  • 213
    Price RA, Li WD, Bernstein A et al. A locus affecting obesity in human chromosome region 10p12. Diabetologia 2001; 44: 3636.
  • 214
    Norman RA, Tataranni PA, Pratley R et al. Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet 1998; 62: 65968.
  • 215
    Hanson RL, Ehm MG, Pettitt DJ et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 1998; 63: 11308.
  • 216
    Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978; 108: 497505.
  • 217
    Stone S, Abkevich V, Hunt SC et al. A major predisposition locus for severe obesity, at 4p15-p14. Am J Hum Genet 2002; 2002: 145968.
  • 218
    Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 509187.
  • 219
    Evans JL, Honer CM, Womelsdorf BE, Kaplan EL, Bell PA. The effects of wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, on insulin-stimulated glucose transport, GLUT4 translocation, antilipolysis, and DNA synthesis. Cell Signal 1995; 7: 36576.
  • 220
    Lee JH, Reed DR, Li WD et al. Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet 1999; 64: 196209.
  • 221
    Butler AA, Kesterson RA, Khong K et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000; 141: 351821.
  • 222
    Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 1995; 9: 16881.
  • 223
    Dong C, Wang S, Li WD, Li D, Zhao H, Price RA. Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity. Am J Hum Genet 2003; 2003: 11524.
  • 224
    Bray GA. Overweight, mortality, and morbidity. In: BouchardC, ed. Physical Activity and Obesity. Champaign, IL: Human Kinetics, 2000; 3153.
  • 225
    Bell J. The New Genetics: the new genetics in clinical practice. BMJ 1998; 316: 618.
  • 226
    Beaudet AL. 1998 ASHG presidential address. Making genomic medicine a reality. Am J Hum Genet 1999; 64: 113.
  • 227
    Evans JP, Skrzynia C, Burke W. The complexities of predictive genetic testing. BMJ 2001; 322: 1052.
  • 228
    Collins FS, McKusick VA. Implications of the human genome project for medical science. JAMA 2001; 285: 540.
  • 229
    Holtzman NA, Marteau TM. Will Genetics Revolutionize Medicine? N Engl J Med 2000; 343: 141.
  • 230
    Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic tests in populations. Lancet 2001; 357: 70912.
  • 231
    Khoury MJ, Wagener DK. Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet 1995; 56: 83544.
  • 232
    Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders WD. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 2003; 72: 63649.
  • 233
    Bouchard C, Perusse L. Genetics of obesity. In: FerranniniE, ZimmetP, DeFronzoR, KeenH, eds. International Textbook of Diabetes Mellitus. New York: Wiley, 2004 (in press).